Administration of bortezomib before and after autologous stem cell transplantation improves outcome in multiple myeloma patients with deletion 17p.

Translated title of the contribution: Administration of bortezomib before and after autologous stem cell transplantation improves outcome in multiple myeloma patients with deletion 17p.

K. Neben, H.M. Lokhorst, A. Jauch, U. Bertsch, T. Hielscher, B. van der Holt, H. Salwender, I.W. Blau, K. Weisel, M. Pfreundschuh, C. Scheid, U. Dührsen, W. Lindemann, I.G. Schmidt-Wolf, N. Peter, C. Teschendorf, H. Martin, M. Haenel, H.G. Derigs, M.S. RaabA.D. Ho, extern van de Velde, D. Hose, P. Sonneveld, H. Goldschmidt

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionAdministration of bortezomib before and after autologous stem cell transplantation improves outcome in multiple myeloma patients with deletion 17p.
Original languageUndefined/Unknown
Pages (from-to)940-948
Number of pages9
JournalBlood
Volume119
Issue number4
Publication statusPublished - 2012

Cite this